Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Topiramate Tablet, Film Coated
Product Images NDC 72162-2481
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 72162-2481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This is a table showing the cumulative rates for the time to the first seizure for two groups of patients taking different doses of topiramate - 50 mg/day and 400 mg/day. The table displays data points for different time intervals in days, with a marked difference in seizure rates between the two groups of patients. The p-value indicates a statistically significant difference between the two groups.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Image (B609e53c 2d69 4437 B2a1 9f322208eb27 565 2)
Label (Lbl721622481)
This text is a package insert for Topiramate tablets containing 50 mg of the active ingredient. It provides storage instructions, warning about verifying prescriptions before dispensing, and information about the manufacturer. The insert also directs pharmacists to provide a Medication Guide to each patient and includes a QR code for more detailed prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
